Maria Benitez
Obstetrics & Gynecology · Palm Springs, CANPI 1700044187
Payments from drug & device makers
Across 100 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$995
- Astellas Pharma US Inc$192
- Mayne Pharma Commercial LLC$127
- Coopersurgical, Inc.$114
- Shield Therapeutics Inc$100
- Sumitomo Pharma America, Inc.$88
- plus $492 from 13 others
What the payments were for
- Food & beverage$2,06298%
- Education$462%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 48 | $995 |
| Astellas Pharma US Inc | 8 | $192 |
| Mayne Pharma Commercial LLC | 11 | $127 |
| Coopersurgical, Inc. | 3 | $114 |
| Shield Therapeutics Inc | 2 | $100 |
| Sumitomo Pharma America, Inc. | 4 | $88 |
| Aspira Women's Health Inc | 3 | $82 |
| Hologic Sales And Service, LLC | 3 | $61 |
| Pfizer | 4 | $61 |
| Biogen | 2 | $48 |
| Organon | 3 | $46 |
| AMAG Pharmaceuticals, Inc. | 2 | $39 |
| Boston Scientific | 1 | $32 |
| Bayer | 1 | $26 |
| Myovant Sciences Inc. | 1 | $25 |
| Merck | 1 | $22 |
| Therapeuticsmd, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$110
How this compares
$2,109 in reported general payments places this provider in the 75th percentile of 3,784 obstetrics & gynecology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 17 | $7,215 |
| Estradiol | 86 | $4,761 |
| ValacyclovirValacyclovir Hcl | 20 | $686 |
| ProgesteroneProgesterone, Micronized | 17 | $522 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $118 |
| Misoprostol | 42 | $63 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $61 | $7,21517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,784 obstetrics & gynecology providers in California.
Other obstetrics & gynecology in Palm Springs
- Peyman BanooniBeverly Hills$9.2M
- Vellore BhupathyWhittier$4.3M
- Edwin RamirezOxnard$3.5M
- Nam TranSan Francisco$3M
- Dmitriy RomanenkoSouth Gate$2.7M
- Anita NelsonTorrance$2.1M
- Oleg BessLos Angeles$1.7M
- Rovena ReaganSan Diego$1.7M
- Dana Shippdel Mar$1.7M
- Vanessa JacobySan Francisco$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.